Cas:105854-98-6 4-tert-butyldiphenyl sulfide manufacturer & supplier

Chemical Name:4-tert-butyldiphenyl sulfide

CAS.NO:105854-98-6

Synonyms:4-tert-butyldiphenyl sulfide

Molecular Formula:C₁₆H₁₈S

Molecular Weight:242.37900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:25.30000

Exact Mass:242.11300

LogP:5.13530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-tert-butyldiphenyl sulfide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-tert-butyldiphenyl sulfide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-tert-butyldiphenyl sulfide Use and application,4-tert-butyldiphenyl sulfide technical grade,usp/ep/jp grade.

Related News: This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 4-tert-butyldiphenyl sulfide manufacturer Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 4-tert-butyldiphenyl sulfide supplier This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 4-tert-butyldiphenyl sulfide vendor Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 4-tert-butyldiphenyl sulfide factory The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.